Pharmaceuticals Singapore

Singapore Direct-to-Consumer Genetic Testing Market Analysis, 2024–2034

Updated Reviewed by Chandani Patel

Singapore Direct-to-Consumer Genetic Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Channel, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

Singapore · 2024–2034 · placeholder estimates

Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $2.4 Mn Placeholder estimate
Estimate 2025 $2.6 Mn 0.1% of the global market
Projected 2034 $7.4 Mn 181.8% Adds $4.8 Mn over 9 forecast years
CAGR 2025–2034 12.2% Faster than 66% of 180 Pharmaceuticals markets here
Key players 5 Companies profiled
  • Singapore is 0.11% of the global market.
  • In APAC, the largest is China at $210.6 Mn.
  • Fastest growing: India at 14.7% a year.
  • Singapore ranks 10th of 10 by size in APAC.

Market size projection

Singapore

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$4.8 Mn total, 2026–2034

Year-by-year market size, 2024–2034
Direct-to-Consumer Genetic Testing Market market size by year, Singapore
YearMarket sizeChange that yearSince 2025
2024 (estimate) $2.4 Mn — —
2025 (base) $2.6 Mn +$0.3 Mn —
2026 (forecast) $3.0 Mn +$0.3 Mn +12.2%
2027 (forecast) $3.3 Mn +$0.4 Mn +25.9%
2028 (forecast) $3.7 Mn +$0.4 Mn +41.2%
2029 (forecast) $4.2 Mn +$0.5 Mn +58.5%
2030 (forecast) $4.7 Mn +$0.5 Mn +77.8%
2031 (forecast) $5.3 Mn +$0.6 Mn +99.5%
2032 (forecast) $5.9 Mn +$0.6 Mn +123.8%
2033 (forecast) $6.6 Mn +$0.7 Mn +151.2%
2034 (forecast) $7.4 Mn +$0.8 Mn +181.8%

Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $2.51 Bn
  2. North America $1.26 Bn
  3. US $891.5 Mn
  4. APAC $592.2 Mn
  5. Europe $423.3 Mn
  6. China $210.6 Mn
  7. Canada $196.9 Mn
  8. Japan $142.5 Mn
  9. Middle East $115.7 Mn
  10. Latin America $111.7 Mn
  11. Germany $96.0 Mn
  12. France $72.4 Mn
  13. Brazil $72.3 Mn
  14. UK $64.0 Mn
  15. Italy $64.6 Mn
  16. Spain $48.0 Mn
  17. India $51.2 Mn
  18. Ecuador $45.9 Mn
  19. Saudi Arabia $46.3 Mn
  20. Africa $40.7 Mn
  21. Mexico $39.5 Mn
  22. Australia $29.5 Mn
  23. New Zealand $28.6 Mn
  24. Russia $24.2 Mn
  25. South Africa $16.8 Mn
  26. UAE $13.5 Mn
  27. Egypt $6.7 Mn
  28. Philippines $4.9 Mn
  29. Hong Kong $4.7 Mn
  30. Malaysia $4.0 Mn
  31. Thailand $2.8 Mn
  32. Singapore (this report) $2.6 Mn
  33. Kenya $2.0 Mn

Report snapshot

Singapore Direct-to-Consumer Genetic Testing Market Analysis at a glance
Market size, 2025$2.6 Mn placeholder estimate
Forecast, 2034$7.4 Mn placeholder estimate
Growth (CAGR), 2025–203412.2% placeholder estimate
Years2024 historical · 2025 base year · 2026–2034 forecast
SegmentsTest and channel (see all)
Key players23andMe, Ancestry, MyHeritage, Nebula Genomics, Inc., Color Health (see all)
Regulator in SingaporeHSASource: Health Sciences Authority. Checked 14 Nov 2026.
FormatsPDF, PPTX, XLSX

Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.

The Singapore Direct-to-Consumer Genetic Testing Market Analysis Executive Summary

Direct-to-consumer genetic tests are bought online by individuals to learn about ancestry, traits and some health risks from a saliva sample.

Key segments of the direct-to-Consumer Genetic Testing market include test (Ancestry, Health Risk and Carrier Status) and channel (Online and Retail).

Bar chart: Singapore Direct-to-Consumer Genetic Testing market size, 2024–2034, placeholder estimates. $2.4 Mn in 2024, $2.6 Mn in 2025 and $7.4 Mn in 2034, 12.2% CAGR.
Singapore Direct-to-Consumer Genetic Testing market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.

Singapore Direct-to-Consumer Genetic Testing Market Dynamics

Market Growth Drivers

The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the direct-to-Consumer Genetic Testing market.

Opportunity

Routine use of genomics in screening, pharmacy and primary care gives the direct-to-Consumer Genetic Testing market large room to grow.

Market Restraints

Data privacy concerns, limited reimbursement for some tests, shortages of genetic counsellors and complex data analysis hold back the direct-to-Consumer Genetic Testing market.

Competitive Landscape for Direct-to-Consumer Genetic Testing Market in Singapore

The direct-to-Consumer Genetic Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Direct-to-Consumer Genetic Testing Market in Singapore

Direct-to-Consumer Genetic Testing in Singapore: rules and payment

Therapeutic products need registration with the Health Sciences Authority (HSA).⁠[1] MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts.⁠[2]

[1] Health Sciences Authority. Checked 14 Nov 2026.

[2] CPF Board, MediShield Life. Checked 14 Nov 2026.

Policy changes and Reimbursement scenario

Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for direct-to-Consumer Genetic Testing. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Singapore.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Direct-to-Consumer Genetic Testing right now, from free public sources.

Latest research 144 papers since 2021 (worldwide)

  1. Misattributed Paternity: Why Truth Must be Pursued. Journal of bioethical inquiry, 2026
  2. Bridging the BRCA1/2 variant previvor gap in health care. JAAPA : official journal of the American Academy of Physician Assistants, 2026
  3. Private information leakage from polygenic risk scores. Genome research, 2026
  4. Experiences of insemination fraud: discovering and navigating unexpected and entangled connections. Human fertility (Cambridge, England), 2026
  5. Common Single Nucleotide Polymorphisms in Clinical Cardiology and Dietary Intervention: A Narrative Review. Nutrients, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Direct-to-Consumer Genetic Testing in context

Singapore compared

  • Health spending per person: 3,922 US$ per person (2023). World: 1,317 US$ per person (2023). 3rd highest of the 15 countries we cover in APAC.[1]
  • Doctors: 2.83 per 1,000 people (2022). World: 1.86 per 1,000 people (2022). 4th highest of the 15 countries we cover in APAC.[2]
  • People aged 65 and over: 14.2% of people (2025). World: 10.4% of people (2025). 7th highest of the 16 countries we cover in APAC.[3]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 14 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 15 Nov 2026.

Free data on this topic

Quick answers

Frequently asked questions

How big is the Direct-to-Consumer Genetic Testing market in Singapore?
Placeholder estimate: about $2.6 Mn in 2025, rising to about $7.4 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the Direct-to-Consumer Genetic Testing market in Singapore growing?
Placeholder estimate: about 12.2% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the Direct-to-Consumer Genetic Testing market report cover?
The report splits the market by test (Ancestry, Health Risk, Carrier Status, Nutrigenomics) and channel (Online, Retail).
Who are the key players in the Direct-to-Consumer Genetic Testing market?
Key players include 23andMe, Ancestry, MyHeritage, Nebula Genomics, Inc. and Color Health.
What is driving the Direct-to-Consumer Genetic Testing market?
The falling cost of DNA sequencing, more targeted medicines, large national genome programmes and growing use of genetic results in everyday care are driving the direct-to-Consumer Genetic Testing market.
Who regulates Direct-to-Consumer Genetic Testing in Singapore?
Therapeutic products need registration with the Health Sciences Authority (HSA). Source: Health Sciences Authority. Checked 14 Nov 2026.
How is healthcare paid for in Singapore?
MediShield Life gives basic health insurance to all citizens and permanent residents, alongside MediSave savings accounts. Source: CPF Board, MediShield Life. Checked 14 Nov 2026.
How much research is published on Direct-to-Consumer Genetic Testing?
PubMed lists 144 papers on Direct-to-Consumer Genetic Testing added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Direct-to-Consumer Genetic Testing in Singapore? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard
Back to Catalogue
Keep exploring

Related Pharmaceuticals reports in Singapore

See all
Same topic, other categories

Related on genomics

See the topic